289 related articles for article (PubMed ID: 18003766)
1. N-acetylcysteine in the prevention of contrast-induced nephropathy.
Fishbane S
Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
[TBL] [Abstract][Full Text] [Related]
2. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
Gawenda M; Möller A; Wassmer G; Brunkwall J
Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
[TBL] [Abstract][Full Text] [Related]
3. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis.
Duong MH; MacKenzie TA; Malenka DJ
Catheter Cardiovasc Interv; 2005 Apr; 64(4):471-9. PubMed ID: 15789388
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of contrast-induced nephropathy.
Al-Ghonaim M; Pannu N
Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology and prevention of contrast-induced acute renal failure].
Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
[TBL] [Abstract][Full Text] [Related]
8. Can we prevent acute kidney injury?
Venkataraman R
Crit Care Med; 2008 Apr; 36(4 Suppl):S166-71. PubMed ID: 18382189
[TBL] [Abstract][Full Text] [Related]
9. Contrast-induced nephropathy.
Pucelikova T; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
[TBL] [Abstract][Full Text] [Related]
10. [Strange but true: acetylcysteine protects against kidney damage caused by iodized contrast media].
Rizzato G
Radiol Med; 2001 Apr; 101(4):287-9. PubMed ID: 11398061
[No Abstract] [Full Text] [Related]
11. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial.
Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O
Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303
[TBL] [Abstract][Full Text] [Related]
12. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
[TBL] [Abstract][Full Text] [Related]
13. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Chousterman BG; Bouadma L; Moutereau S; Loric S; Alvarez-Gonzalez A; Mekontso-Dessap A; Laissy JP; Rahmouni A; Katsahian S; Brochard L; Schortgen F
J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
[TBL] [Abstract][Full Text] [Related]
14. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
15. Hydration and N-acetylcysteine in acute renal failure caused by iodinated contrast medium: an experiment with rats.
Pinto CF; Watanabe M; Vattimo Mde F
J Nephrol; 2008; 21(5):783-8. PubMed ID: 18949735
[TBL] [Abstract][Full Text] [Related]
16. Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study.
Moore NN; Lapsley M; Norden AG; Firth JD; Gaunt ME; Varty K; Boyle JR
J Endovasc Ther; 2006 Oct; 13(5):660-6. PubMed ID: 17042662
[TBL] [Abstract][Full Text] [Related]
17. Prevention of contrast-induced nephropathy: a critical review.
Van Praet JT; De Vriese AS
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
[TBL] [Abstract][Full Text] [Related]
18. Preventing contrast nephropathy: what is the best strategy? A review of the literature.
Cox CD; Tsikouris JP
J Clin Pharmacol; 2004 Apr; 44(4):327-37. PubMed ID: 15051739
[TBL] [Abstract][Full Text] [Related]
19. N-acetylcysteine for contrast nephropathy: more clinical science is required.
Eddleston M; Goddard J; Bateman N
Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
[No Abstract] [Full Text] [Related]
20. N-acetylcysteine to prevent contrast nephropathy.
Meine TJ; Washam JB
Am Heart J; 2004 Mar; 147(3):440-1. PubMed ID: 14999191
[No Abstract] [Full Text] [Related]
[Next] [New Search]
